Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
19.83
-1.18 (-5.62%)
At close: Mar 3, 2026, 4:00 PM EST
20.34
+0.51 (2.57%)
After-hours: Mar 3, 2026, 7:01 PM EST
Amphastar Pharmaceuticals Market Cap
Amphastar Pharmaceuticals has a market cap or net worth of $899.69 million as of March 3, 2026. Its market cap has decreased by -41.05% in one year.
Market Cap
899.69M
Enterprise Value
1.27B
1-Year Change
-41.05%
Ranking
Category
Stock Price
$19.83
Market Cap Chart
Since June 25, 2014, Amphastar Pharmaceuticals's market cap has increased from $374.20M to $899.69M, an increase of 140.43%. That is a compound annual growth rate of 7.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 953.20M | -22.54% |
| Dec 31, 2025 | 1.23B | -31.07% |
| Dec 31, 2024 | 1.79B | -39.75% |
| Dec 29, 2023 | 2.96B | 118.81% |
| Dec 30, 2022 | 1.35B | 21.52% |
| Dec 31, 2021 | 1.11B | 16.65% |
| Dec 31, 2020 | 955.30M | 5.51% |
| Dec 31, 2019 | 905.40M | -1.31% |
| Dec 31, 2018 | 917.40M | 3.71% |
| Dec 29, 2017 | 884.60M | 4.34% |
| Dec 30, 2016 | 847.80M | 32.34% |
| Dec 31, 2015 | 640.60M | 23.57% |
| Dec 31, 2014 | 518.40M | 38.54% |
| Jun 25, 2014 | 374.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amylyx Pharmaceuticals | 1.55B |
| Harrow | 1.44B |
| Collegium Pharmaceutical | 1.27B |
| Alvotech | 1.19B |
| Evotec SE | 1.09B |
| Cronos Group | 996.36M |
| Pacira BioSciences | 894.83M |
| Tilray Brands | 857.49M |